Complicated Non-Stenotic Carotid Plaques: A Light in the Diagnosis of Cryptogenic Stroke?

Stroke is one of the leading causes of death and disability. It produces great morbidity by causing marked post-event cognitive impairment. Recurrence of an ischemic event may vary according to the cause of the stroke. Complicated non-stenotic carotid plaque (CCP) type VI (according to the American Heart Association [AHA] classification) has been described as an under-recognized cause in the diagnosis of stroke.

Placas carotídeas complicadas no estenosantes ¿una luz en el diagnóstico del ACV criptogénico?

CCP is defined as plaque with a ruptured fibrous cap, intraplaque hemorrhage (IPAH), or mural thrombosis. It can be accurately diagnosed by carotid magnetic resonance angiography (dark blood technique).

The AHA classifies it into type I-II (normal thickness, without calcification), type III (diffuse intimal thickening, without calcification), type IV/V (plaque with lipid or necrotic core surrounded by fibrous tissue with possible calcification), type VI (complicated plaque with surface defects or thrombus), type VII (calcified plaque), and type VIII (fibrotic plaque without lipid core and with small calcifications).

Currently, there are no studies that have assessed its search in the first days after stroke (acute stage), especially in patients labeled as cryptogenic stroke.

The CAPIAS (carotid plaque imaging in acute stroke) is an observational, prospective, multicenter study conducted in Germany, looking to define the role of CCP in the recurrence of ischemic stroke or transient ischemic attack (TIA) compared with patients without CCP.

Read also: Takotsubo Syndrome: Does Gender Impact Prognosis?

Researchers included patients older than 49 years, within 10 days after an ischemic stroke, with a single area involved (attributable to carotid artery), with carotid plaque ≥2 mm. Patients with carotid stenosis ≥70% or dissection were excluded. The primary endpoint (PEP) was a composite of recurrent ischemic stroke or TIA. Secondary endpoints (SEP) were recurrent ischemic stroke and ipsilateral recurrent ischemic stroke or TIA.

Data were obtained from 196 patients, of whom 104 had been diagnosed with cryptogenic stroke. Twenty-nine percent had a baseline ipsilateral CCP. On average, 21 patients had recurrence of ischemic stroke or TIA.

The incidence rate of the PEP was significantly higher in patients with ipsilateral CCP (9.50 per 100 patient-years) compared with patients without CCP (3.61 per 100 patient-years; p = 0.025). Adjusted for age and sex, ipsilateral CCP was associated with 2.5 times higher risk of recurrence at 3 years (hazard ratio [HR]: 2.51; 95% confidence interval [CI]: 1.03-6.11; p = 0.043).

Read also: IN.PACT Global: Follow Up of Real-Life Patient in Femoropopliteal Territory.

When analyzing the characteristics of CCPs by MRI, the presence of ruptured fibrous cap was mostly associated with ischemic events (HR: 2.61; 95% CI: 1.01-7.05; p = 0.041), whereas the presence of intraplaque hemorrhage was associated with an increased risk of events in patients with cryptogenic stroke (HR: 4.37; 95% CI: 1.20-15.97; p = 0.026).

Conclusions

This study showed that ipsilateral CCP detected by MRI angiography within 10 days of stroke was associated with an increased risk of recurrent stroke or TIA. These findings were mainly in patients diagnosed with cryptogenic stroke. Whether the treatment of these patients should include more aggressive medical treatment or carotid interventions has not been studied, but from the data shown on recurrence in this research it should be considered as a field to be developed.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Complicated Carotid Artery Plaques and Risk of Recurrent Ischemic Stroke or TIA.

Reference: Kopczak, Anna et al. “Complicated Carotid Artery Plaques and Risk of Recurrent Ischemic Stroke or TIA.” Journal of the American College of Cardiology vol. 79,22 (2022): 2189-2199. doi:10.1016/j.jacc.2022.03.376.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...